Home Compare AFX.DE
Peer Analysis

Carl Zeiss Meditec AG — Peer Companies & Stock Comparisons

Carl Zeiss Meditec AG's functional peer companies ranked by peer score — growth, valuation, profitability and stability compared.

Compare AFX.DE with peers
Comparison AFX.DE peer score
Carl Zeiss Meditec AG vs Solventum Corporation
70 Compare →
Carl Zeiss Meditec AG vs Labcorp Holdings Inc.
50 Compare →
Carl Zeiss Meditec AG vs Mowi ASA
58 Compare →
Carl Zeiss Meditec AG vs Sonova Holding AG
49 Compare →
Carl Zeiss Meditec AG vs Leonardo DRS, Inc.
41 Compare →
Carl Zeiss Meditec AG vs Sandoz Group AG
53 Compare →
Carl Zeiss Meditec AG vs Align Technology, Inc.
59 Compare →
Carl Zeiss Meditec AG vs The Hershey Company
50 Compare →
Carl Zeiss Meditec AG vs UnitedHealth Group Incorporated
46 Compare →
Carl Zeiss Meditec AG vs Amplifon S.p.A.
24 Compare →

Full AFX.DE analysis in AssetNext

View the complete Carl Zeiss Meditec AG report including all peer dimensions.

Open in AssetNext →

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.